Comparative effects of formoterol monotherapy versus formoterol plus tiotropium on dynamic hyperinflation and exercise tolerance in COPD Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009
Mechanisms of improved exercise tolerance in COPD in response to tiotropium Source: Eur Respir J 2002; 20: Suppl. 38, 288s Year: 2002
Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006
Effect of a single dose of formoterol and tiotropium in exercise tolerance in COPD patients: preliminary data Source: Eur Respir J 2003; 22: Suppl. 45, 405s Year: 2003
Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD Source: Eur Respir J 2006; 28: Suppl. 50, 172s Year: 2006
Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol Source: Eur Respir J 2001; 17: 368-373 Year: 2001
Budesonide/formoterol improves exercise tolerance compared with placebo and formoterol in COPD patients Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009
Effect of fluticasone propionate/salmeterol on exercise endurance in moderate-severe COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006
Effects of tiotropium on neurohumoral activation during exercise in stable COPD patients Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
The impact of tiotropium for exercise induced bronchoconstriction Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Lack of tolerance to the bronchoprotective effect with intermittent administration of salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 710s Year: 2006
Intermittent administration of salmeterol does not induce tolerance to the bronchoprotective effect in exercise induced bronchoconstriction Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003
Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD Source: International Congress 2014 – Asthma and COPD management Year: 2014
Effect of heliox on exercise capacity in COPD Source: ERS Course 2017 Year: 2017
Addition of theophylline to standard inhalatory therapy in patients with stable COPD: effects on exercise tolerance Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
The effect of long-term administration of inhaled formoterol on VO2 max of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 322s Year: 2004
Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD Source: Annual Congress 2004 - Exercise and systemic effects in COPD Year: 2004
Impact of bronchodilator on pulmonary function and exercise tolerance in LAM Source: Annual Congress 2011 - Lung and airway function Year: 2011